10-Q 1 findit_10q-093023.htm 10-Q
false --12-31 2023 Q3 0001593184 0001593184 2023-01-01 2023-09-30 0001593184 2023-11-20 0001593184 2023-09-30 0001593184 2022-12-31 0001593184 us-gaap:SeriesAPreferredStockMember 2023-09-30 0001593184 us-gaap:SeriesAPreferredStockMember 2022-12-31 0001593184 us-gaap:SeriesBPreferredStockMember 2023-09-30 0001593184 us-gaap:SeriesBPreferredStockMember 2022-12-31 0001593184 2023-07-01 2023-09-30 0001593184 2022-07-01 2022-09-30 0001593184 2022-01-01 2022-09-30 0001593184 us-gaap:CommonStockMember 2022-12-31 0001593184 FDIT:PreferredStockSeriesAMember 2022-12-31 0001593184 FDIT:PreferredStockSeriesBMember 2022-12-31 0001593184 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001593184 us-gaap:RetainedEarningsMember 2022-12-31 0001593184 us-gaap:CommonStockMember 2023-03-31 0001593184 FDIT:PreferredStockSeriesAMember 2023-03-31 0001593184 FDIT:PreferredStockSeriesBMember 2023-03-31 0001593184 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001593184 us-gaap:RetainedEarningsMember 2023-03-31 0001593184 2023-03-31 0001593184 us-gaap:CommonStockMember 2023-06-30 0001593184 FDIT:PreferredStockSeriesAMember 2023-06-30 0001593184 FDIT:PreferredStockSeriesBMember 2023-06-30 0001593184 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001593184 us-gaap:RetainedEarningsMember 2023-06-30 0001593184 2023-06-30 0001593184 us-gaap:CommonStockMember 2021-12-31 0001593184 FDIT:PreferredStockSeriesAMember 2021-12-31 0001593184 FDIT:PreferredStockSeriesBMember 2021-12-31 0001593184 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001593184 us-gaap:RetainedEarningsMember 2021-12-31 0001593184 2021-12-31 0001593184 us-gaap:CommonStockMember 2022-03-31 0001593184 FDIT:PreferredStockSeriesAMember 2022-03-31 0001593184 FDIT:PreferredStockSeriesBMember 2022-03-31 0001593184 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001593184 us-gaap:RetainedEarningsMember 2022-03-31 0001593184 2022-03-31 0001593184 us-gaap:CommonStockMember 2022-06-30 0001593184 FDIT:PreferredStockSeriesAMember 2022-06-30 0001593184 FDIT:PreferredStockSeriesBMember 2022-06-30 0001593184 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001593184 us-gaap:RetainedEarningsMember 2022-06-30 0001593184 2022-06-30 0001593184 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001593184 FDIT:PreferredStockSeriesAMember 2023-01-01 2023-03-31 0001593184 FDIT:PreferredStockSeriesBMember 2023-01-01 2023-03-31 0001593184 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001593184 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001593184 2023-01-01 2023-03-31 0001593184 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001593184 FDIT:PreferredStockSeriesAMember 2023-04-01 2023-06-30 0001593184 FDIT:PreferredStockSeriesBMember 2023-04-01 2023-06-30 0001593184 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001593184 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001593184 2023-04-01 2023-06-30 0001593184 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001593184 FDIT:PreferredStockSeriesAMember 2023-07-01 2023-09-30 0001593184 FDIT:PreferredStockSeriesBMember 2023-07-01 2023-09-30 0001593184 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001593184 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001593184 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001593184 FDIT:PreferredStockSeriesAMember 2022-01-01 2022-03-31 0001593184 FDIT:PreferredStockSeriesBMember 2022-01-01 2022-03-31 0001593184 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001593184 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001593184 2022-01-01 2022-03-31 0001593184 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001593184 FDIT:PreferredStockSeriesAMember 2022-04-01 2022-06-30 0001593184 FDIT:PreferredStockSeriesBMember 2022-04-01 2022-06-30 0001593184 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001593184 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001593184 2022-04-01 2022-06-30 0001593184 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001593184 FDIT:PreferredStockSeriesAMember 2022-07-01 2022-09-30 0001593184 FDIT:PreferredStockSeriesBMember 2022-07-01 2022-09-30 0001593184 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001593184 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001593184 us-gaap:CommonStockMember 2023-09-30 0001593184 FDIT:PreferredStockSeriesAMember 2023-09-30 0001593184 FDIT:PreferredStockSeriesBMember 2023-09-30 0001593184 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001593184 us-gaap:RetainedEarningsMember 2023-09-30 0001593184 us-gaap:CommonStockMember 2022-09-30 0001593184 FDIT:PreferredStockSeriesAMember 2022-09-30 0001593184 FDIT:PreferredStockSeriesBMember 2022-09-30 0001593184 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001593184 us-gaap:RetainedEarningsMember 2022-09-30 0001593184 2022-09-30 0001593184 FDIT:ChillNOutCryotherapyMember 2020-11-25 0001593184 FDIT:ChillNOutCryotherapyMember 2023-09-30 0001593184 FDIT:ChillNOutCryotherapyMember 2022-12-31 0001593184 FDIT:ChillNOutCryotherapyMember 2023-01-01 2023-09-30 0001593184 FDIT:ChillNOutCryotherapyMember 2022-01-01 2022-09-30 0001593184 FDIT:EIDLMember 2020-07-19 2020-07-20 0001593184 FDIT:EIDLMember 2021-07-16 2021-07-17 0001593184 FDIT:SBALoan2020Member 2023-09-30 0001593184 FDIT:SBALoan2020Member 2022-12-31 0001593184 FDIT:SBALoan2021Member 2023-09-30 0001593184 FDIT:SBALoan2021Member 2022-12-31 0001593184 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001593184 FDIT:ClassworxMember 2022-01-01 2022-12-31 0001593184 FDIT:ClassworxMember 2023-09-30 0001593184 FDIT:ThomasPowersMember 2022-01-01 2022-12-31 0001593184 FDIT:ThomasPowersMember 2023-03-30 2023-03-31 0001593184 FDIT:ThomasPowersMember 2023-01-01 2023-09-30 0001593184 FDIT:TransworldNewsMember 2022-01-01 2022-12-31 0001593184 FDIT:TransworldNewsMember 2022-12-31 0001593184 FDIT:TransworldNewsMember 2023-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: September 30, 2023

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____________to

 

Commission file number: 000-56345

 

FINDIT, INC.

(Exact name of Company in its charter)

 

Nevada   30-1912453
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification)

 

5051 Peachtree Corners, #200

Peachtree Corners, GA 30092

(Address of principal executive offices, including zip code)

 

Registrant's Telephone number, including area code: (843) 532-1759

 

Securities registered pursuant to Section 12(b) of the Act: None

Securities registered pursuant to Section 12(g) of the Act: Common Stock, $0.001 par value

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for at least the part 90 days.

Yes No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (section 232.406 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company.

 

Large accelerated filer   Accelerated filer
Non-accelerated filer   Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

 

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date. The number of shares outstanding of the registrant's only class of common stock, as of November 20, 2023 was 276,750,406 shares of its $0.001 par value common stock.

 

No documents are incorporated into the text by reference.

 

   

 

 

 

PART I - FINANCIAL INFORMATION

 

This Quarterly Report includes forward-looking statements within the meaning of the Securities Exchange Act of 1934. These statements are based on management’s beliefs and assumptions, and on information currently available to management. Forward-looking statements include the information concerning our possible or assumed future results of operations set forth under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Forward-looking statements also include statements in which words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “consider,” or similar expressions are used.

 

Forward-looking statements are not guarantees of future performance. They involve risks, uncertainties, and assumptions. Our future results and shareholder values may differ materially from those expressed in these forward-looking statements. Readers are cautioned not to put undue reliance on any forward-looking statements.

 

 

Item 1. Financial Statements

 

Condensed Balance Sheets as of September 30, 2023 (unaudited) and December 31, 2022 (audited) 3
Condensed Statements of Operations for the three and nine months dated September 30, 2023 and 2022 (unaudited) 4
Condensed Statement of Stockholders’ Deficit for the three and nine months ended September 30, 2023 and 2022 (unaudited) 5
Condensed Statements of Cash Flows for the nine months ended September 30, 2023 and 2022 (unaudited) 6
Notes to the Financial Statements (unaudited) 7

 

 

 

 

 

 2 

 

 

FINDIT, INC.

CONDENSED BALANCE SHEETS

 

 

   September 30, 2023   December 31, 2022 
ASSETS          
Current Assets:          
Cash  $758   $676 
Total Current Assets   758    676 
           
Non-Current Assets:          
Domain Name & Website, net of amortization of $55,958 and $51,509, respectively   33,023    37,473 
Investment in Chill N Out Chryotherapy – related party   200    21,000 
Total Other Assets   33,223    58,473 
Total Assets  $33,981   $59,149 
           
LIABILITIES & STOCKHOLDERS' DEFICIT          
Current Liabilities:          
Accounts Payable and Accrued Expenses  $26,144   $19,721 
Current Portion Long-Term Debt   200,000    4,189 
Loans Payable – Related Party   14,390    40,970 
Total Current Liabilities   240,534    64,880 
           
Long-Term Debt       195,811 
           
Total Liabilities   240,534    260,691 
           
Stockholders' Deficit:          
Preferred Stock, Series A, $0.001 par value, 50,000,000 shares authorized, 5,000,000 shares issued and outstanding   5,000    5,000 
Preferred Stock, Series B, $0.001 par value, 5,000,000 shares authorized, 4,900,000 shares issued and outstanding   4,900    4,900 
Common Stock, $0.001 par value, 500,000,000 shares authorized, 276,750,406 and 269,745,006 issued and outstanding, respectively   276,750    269,745 
Additional Paid in Capital   3,001,149    2,436,513 
Accumulated Deficit   (3,494,352)   (2,917,700)
Total Stockholders' Deficit   (206,553)   (201,542)
Total Liabilities and Stockholders' Deficit  $33,981   $59,149 

 

The accompanying notes are an integral part of these unaudited financial statements.

 

 

 3 

 

  

FINDIT, INC.

STATEMENTS OF OPERATIONS

(Unaudited)

 

 

                             
  

Three Months Ended

September 30,

  

Nine Months Ended

September 30,

 
   2023   2022   2023   2022 
Revenues:                
Findit Services  $3,690   $11,283   $17,175   $33,245 
                     
Operating Expenses:                    
Advertising and Marketing Expenses           245    6,043 
Amortization Expense   1,483    1,483    4,449    4,449 
Consulting Services           81,600     
Content Writing               21,750 
General and Administrative Expense   1,003    6,374    12,061    20,884 
Professional Fees       836    1,800    27,613 
Programming Fees       1,100    700    9,150 
Web Design and Hosting Expense   2,849    3,681    12,762    16,129 
Total Operating Expenses   5,335    13,474    113,617    106,018 
                     
Loss from Operations   (1,645)   (2,191)   (96,442)   (72,773)
                     
Other Expense:                    
Loss on conversion of debt – related party           (453,232)    
Interest Expense   (2,046)       (6,178)    
Total Other Expense   (2,046)       (459,410)    
                     
Loss Before Provision for Income Tax   (3,691)   (2,191)   (555,852)   (72,773)
Provision for Income Tax                
Net Loss   (3,691)   (2,191)   (555,852)   (72,773)
                     
Other Comprehensive Income (Loss)                    
Unrealized gain (loss) on available-for-sale securities   (50,800)   20,400    (20,800)   (39,000)
Total Comprehensive Income (Loss)  $(54,491)  $18,209   $(576,652)  $(111,773)
                     
Income (Loss) Per Share, Basic and Diluted  $(0.00)  $0.00   $(0.00)  $(0.00)
Weighted Average Shares Outstanding, Basic and Diluted   269,745,006    269,745,006    269,745,006    269,745,006 

 

 

The accompanying notes are an integral part of these unaudited financial statements.

 

 

 4 

 

 

FINDIT, INC.

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ (DEFICIT) EQUITY

For the Three and Nine Months Ended September 30, 2023 and 2022

 

 

                                                       
   Common Stock   Preferred Stock,
Series A
   Preferred Stock,
Series B
   Additional Paid in   Accumulated   Total Stockholders’ 
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Equity 
Balance, December 31, 2022   269,745,006   $269,745    5,000,000   $5,000    4,900,000   $4,900   $2,436,513   $(2,917,700)  $(201,542)
Shares issued for services   1,000,000    1,000                    80,600        81,600 
Shares issued for debt and services – related party   6,005,400    6,005                    484,036        490,041 
Net Loss                               (527,033)   (527,033)
Balance, March 31, 2023   276,750,406    276,750    5,000,000    5,000    4,900,000    4,900    3,001,149    (3,444,733)   (156,934)
Net Loss                               4,872    4,872 
Balance, June 30, 2023   276,750,406    276,750    5,000,000    5,000    4,900,000    4,900    3,001,149    (3,439,861)   (152,062)
Net Loss                               (54,491)   (54,491)
Balance, September 30, 2023   276,750,406   $276,750    5,000,000   $5,000    4,900,000   $4,900   $3,001,149   $(3,494,352)  $(206,553)

 

 

   Common Stock   Preferred Stock,
Series A
   Preferred Stock,
Series B
   Additional Paid in   Accumulated   Total Stockholders’ 
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Equity 
Balance, December 31, 2021   269,745,006   $269,745    5,000,000   $5,000    4,900,000   $4,900   $2,436,513   $(2,800,392)  $(84,234)
Net Loss                               (17,319)   (17,319)
Balance, March 31, 2022   269,745,006    269,745    5,000,000    5,000    4,900,000    4,900    2,436,513    (2,817,711)   (101,553)
Net Loss                               (112,663)   (112,663)
Balance, June 30, 2022   269,745,006    269,745    5,000,000    5,000    4,900,000    4,900    2,436,513    (2,930,374)   (214,216)
Net income                               18,209    18,209 
Balance, September 30, 2022   269,745,006   $269,745    5,000,000   $5,000    4,900,000   $4,900   $2,436,513   $(2,912,165)  $(196,007)

 

 

The accompanying notes are an integral part of these unaudited financial statements.

 

 

 5 

 

 

FINDIT, INC.

CONDENSED STATEMENTS OF CASHFLOWS

(Unaudited)

 

               
   For the Nine Months Ended
September 30,
 
Cash Flow from Operating Activities:  2023   2022 
Net Loss  $(576,652)  $(111,773)
Adjustments to reconcile net loss to net cash used by operating activities:          
Amortization expense   4,449    4,449 
Investment in Chill N Out Cryotherapy – related party   20,800    39,000 
Common stock issued for services   81,600     
Common stock issued for expenses– related party   8,539     
Loss on conversion of debt – related party   453,232     
Changes in Operating Assets and Liabilities:          
Accounts payable   6,424    5,369 
Deferred revenue       2,667 
Net Cash Used by Operating Activities   (1,608)   (60,288)
           
Cash Flows from Investing Activities        
           
Cash Flows from Financing Activities          
Repayment of loans – related party   (110)    
Proceeds from loans payable – related party   1,800    37,471 
Net Cash Provided by Financing Activities   1,690    37,471 
           
Net Change in Cash   81    (22,817)
           
Cash at Beginning of Period   676    24,358 
           
Cash at End of Period  $758   $1,541 
           
Cash Paid During the Period for:          
Interest  $   $ 
Income Taxes  $   $ 
           
Supplemental non-cash disclosure:          
Unrealized loss on available-for-sale securities  $(20,800)  $(39,000)
Common stock issued debt – related party  $   $28,270 

 

The accompanying notes are an integral part of these unaudited financial statements.

 

 

 6 

 

 

FINDIT, INC.

NOTES TO THE UNAUDITED FINANCIAL STATEMENTS

SEPTEMBER 30, 2023

 

 

NOTE 1 – ORGANIZATION & NATURE OF OPERATIONS

 

FINDIT, Inc., “the Company”, was organized on December 23, 1998 as a Nevada Corporation. The Company offers online products and services that consists of content distribution, content creation, web development, Search Engine Optimization, Social Media, and Social Networking Marketing Campaigns. Products and services include news and press release distribution, Findit extension domains we call Vanity Keyword URLs, Findit Prime which is a bundled package of press release distribution, vanity URL, URL submissions into the Findit search engine and social media promoted posts.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

Our unaudited condensed financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”), and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). These financial statements and the notes attached hereto should be read in conjunction with the financial statements and notes included in our financial statements for the fiscal year ended December 31, 2022. In the opinion of our management, all adjustments, including normal recurring adjustments necessary to present fairly our financial position, as of September 30, 2023, and the results of our operations and cash flows for the three months then ended have been included. The results of operations for the interim period are not necessarily indicative of the results for the full year ending December 31, 2023.

 

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Revenue Recognition

The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. Once a contract is determined to be within the scope of ASC 606 at contract inception, the Company reviews the contract to determine which performance obligations the Company must deliver and which of these performance obligations are distinct. The Company recognizes as revenues the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied.

 

Intangible Assets

Intangible assets are amortized over a period of fifteen years on a straight-line basis and consist principally of the cost to acquire the Company’s domain name.

 

Recently Issued Accounting Pronouncements

The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

 

NOTE 3 – GOING CONCERN

 

The accompanying financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has incurred losses since inception resulting in an accumulated deficit of $3,494,352 as of September 30, 2023, and further losses are anticipated in the development of its business raising substantial doubt about the Company’s ability to continue as a going concern.

 

 

 

 7 

 

 

The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations as they come due. Management intends to finance operating costs over the next twelve months with existing cash on hand, and/or private placement of common stock.

 

In order to mitigate the conditions that raise substantial doubt about our ability to continue as a going concern, the company has exited the CBD oil business which consumed substantial capital and resources and has streamlined operational costs.

 

NOTE 4 – INVESTMENTS

 

On November 25, 2020, the Company purchased 1,000,000 shares of the common stock of Chill N Out Cryotherapy at $0.01 per share in exchange for technical services provided. This investment meets the criteria of level one inputs for which quoted market prices are available in active markets for identical assets or liabilities as of the reporting date. As of September 30, 2023 and December 31, 2022, the shares of Chill N Out Cryotherapy have a reported market value of $200 and $21,000, respectively. The Company has adjusted the reported amounts for these investments to market value resulting in an unrealized loss of $20,800 and $39,000 for the nine months ended September 30, 2023 and 2022, respectively.

 

NOTE 5 – DEBT

 

The Company borrowed $150,000 utilizing the Small Business Administration’s Economic Injury Disaster Loan Program. The loan is repayable at 3.75% beginning one year after the proceeds were received which was July 20, 2020. Subsequently Congress has extended the repayment period to one year after the initial date, or July 20, 2022.

 

The Company borrowed $50,000 utilizing the Small Business Administration’s Economic Injury Disaster Loan Program. The loan is repayable at 3.75% beginning two years after the proceeds were received which was July 17, 2021.

 

As of September 30, 2023, no payments towards the balance due and the loan may be considered in default.

 

   September 30, 2023   December 31, 2022 
SBA Loan – July 20, 2020  $150,000   $150,000 
SBA Loan – July 17, 2021   50,000    50,000 
Total  $200,000   $200,000 
Less: current portion   (200,000   (4,189)
Long term portion  $   $195,811 

 

NOTE 6 – PREFERRED STOCK

 

Series A Preferred Stock

The Series A Preferred Stock holds a voting weight of 2,500 common shares, is not entitled to receive dividends and has no liquidation rights.

 

Series B Preferred Stock

The Series B Preferred Stock holds a voting weight of 1,000 common shares, is not entitled to receive dividends and has no liquidation rights.

 

NOTE 7 – COMMON STOCK TRANSACTIONS

 

During the nine months ended September 30, 2023, the Company issued 1,000,000 shares of common stock for services. The shares were valued at $0.0816, the closing stock price on the date of grant, for total non-cash compensation expense of $81,600.

 

NOTE 8 – RELATED PARTY TRANSACTIONS

 

During the year ended December 31, 2022, the Company received a total cash advance from Classworx Inc of $2,900. Classworx Inc, has the same management and majority shareholders as the Company. The advance was for general operating expenses, is non-interest bearing and due on demand. The balance due as of September 30, 2023, is $2,890.

 

During the year ended December 31, 2022, the Company received a total cash advance from Thomas Powers, CEO of $28,270. On March 31, 2023, the Company issued 6,005,400 shares of common stock to Mr. Powers, for $28,270 of debt and $8,539 for expense reimbursement. The shares were valued at $0.0816, the closing stock price on the date of grant, resulting in a loss on the issuance of $453,232.

 

 

 

 8 

 

 

During the year ended December 31, 2022, the Company received a total cash advance from TransworldNews, Inc. of $10,500, $700 of which was repaid, for a balance due of $9,800 as of December 31, 2022. TransworldNews has the same management and majority shareholders as the Company. The advance was for general operating expenses, is non-interest bearing and due on demand. The balance due as of September 30, 2023, is $9,700.

 

During the nine months ended September 30, 2023, Mr. Powers advanced the Company $1,800 to pay for professional fees. The advanced is non-interest bearing and due on demand.

 

NOTE 9 - SUBSEQUENT EVENTS

 

Management has evaluated subsequent events pursuant to the requirements of ASC Topic 855, from the balance sheet date through the date the financial statements were issued and has determined that there are no material subsequent events that require disclosure in these financial statements.

 

 

 

 

 

 

 

 

 9 

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Overview of Current Operations

 

Findit continues as a premium content management platform that enables members to post and manage status updates, podcasts and music, pictures, and video. All posted contented is optimized for SEO and sharing to social networks. Findit also indexes all content in its own search engine for easy retrieval and content discovery. Members can create their own, unique internet URL on Findit to further optimize indexing, search results placement and citation in internet search engines. Findit is an open platform meaning that all content is discoverable by search engines for indexing. Findit is focused on the development of monetized internet-based web products and content.

 

Results of Operations

 

For the three months ended September 30, 2023 and 2022

For the three months ended September 30, 2023, the Company received total revenues from Findit services of $3,690 with cost of goods sold of $0 resulting in a gross margin of $3,690. Comparatively, for the three months ended September 30, 2022, the Company received total revenues from Findit services of $11,283 with cost of goods sold of $0 resulting in a gross margin of $11,283.

 

For the three months ended September 30, 2023, the Company incurred total operating expenses of $5,335 which consisted of amortization expense of $1,483, web design and hosting expense of $2,849 and general and administrative expenses of $1,003. Comparatively, for the three months ended September 30, 2022, the Company incurred total operating expenses of $13,474 which consisted of amortization expense of $1,483, professional fees of $836, programming fees of $1,100, web design and hosting expense of $3,681 and general and administrative expenses of $6,374.

 

For the three months ended September 30, 2023 and 2022, the Company had a loss from operations of ($1,645) and $(2,191), respectively.

 

For the three months ended September 30, 2023 and 2022, the Company had interest expense of $(2,046) and $0, respectively resulting in total other expense of $(2,046) and $0 for the respective periods.

 

For the three months ended September 30, 2023 and 2022, the Company had a net loss of $(3,691) and $(2,191), respectively.

 

For the three months ended September 30, 2023 and 2022, the Company had an unrealized gain (loss) on available-for-sale securities of $(50,800) and $20,400, respectively resulting in total comprehensive income (loss) of $(54,491) and $18,209, respectively.

 

For the nine months ended September 30, 2023 and 2022

For the nine months ended September 30, 2023, the Company received total revenues from Findit services of $17,175 with cost of goods sold of $0 resulting in a gross margin of $17,175. Comparatively, for the nine months ended September 30, 2022, the Company received total revenues from Findit services of $33,245 with cost of goods sold of $0 resulting in a gross margin of $33,245.

 

For the nine months ended September 30, 2023, the Company incurred total operating expenses of $113,617 which consisted of advertising and marketing expenses of $245, amortization expense of $4,449, consulting services of $81,600, web design and hosting expense of $12,762, professional fees of $1,800, programming fees of $700 and general and administrative expenses of $12,061. Comparatively, for the nine months ended September 30, 2022, the Company incurred total operating expenses of $106,018 which consisted of advertising and marketing expenses of $6,043, amortization expense of $4,449, content writing of $21,750, professional fees of $27,613, programming fees of $9,150, web design and hosting expense of $16,129 and general and administrative expenses of $20,884.

 

For the nine months ended September 30, 2023 and 2022, the Company had a loss from operations of ($96,442) and $(72,773), respectively.

 

For the nine months ended September 30, 2023 and 2022, the Company had loss on conversion of debt-related party of $(453,232) and $0, respectively and interest expense of $(6,178) and $0, respectively resulting in total other expense of $(459,410) and $0 for the respective periods.

 

For the nine months ended September 30, 2023 and 2022, the Company had a net loss of $(555,852) and $(72,773), respectively.

 

For the nine months ended September 30, 2023 and 2022, the Company had an unrealized gain (loss) on available-for-sale securities of $(20,800) and $39,000, respectively resulting in total comprehensive income (loss) of $(576,652) and $(111,773), respectively.

 

 

 10 

 

 

Liquidity and Capital Resources

 

For the nine months ended September 30, 2023 and 2022

For the nine months ended September 30, 2023, the Company had a net loss of $(576,652). For the nine months ended September 30, 2023, the Company incurred amortization expense of $4,449, investment in Chill N Out Cryotherapy-related party of $20,800, common stock issued for services of $81,600, common stock issued for expenses-related party of $8,539, loss on conversion of debt-related party of $453,232 and accounts payable of $6,424 resulting in net cash used by operating activities of $(1,608).

 

For the nine months ended September 30, 2022, the Company had a net loss of $(111,773). For nine months ended September 30, 2022, the Company incurred amortization expense of $4,449, investment in Chill N Out Cryotherapy-related party of $39,000, accounts payable of $5,369 and deferred revenue of $2,667 resulting in net cash used by operating activities of $(60,288).

 

For the nine months ended September 30, 2023 and 2022, the Company did not pursue any investing activities.

 

For the nine months ended September 30, 2023, the Company made repayment of loans-related party of $(110) and proceeds from loans payable-related party of $1,800 resulting in net cash used by financing activities of $(1,690).

 

For the nine months ended September 30, 2023, the Company had proceeds from loans payable – related party of $37,471.

 

Management intends to raise additional debt or equity financing to fund ongoing operations and for necessary working capital. However, there is no assurance that such financing plans will be successful or be obtained in amounts sufficient to meet the Company’s needs.

 

Notwithstanding, the Company anticipates generating losses and therefore may be unable to continue operations in the future. The Company anticipates it will require additional capital in order to develop its business. The Company may use a combination of equity and/or debt instruments or enter into a strategic arrangement with a third party. Management has yet to find a solution to its funding requirements.

 

Going Concern

 

Our ability to continue as a going concern is contingent upon the successful completion of additional financing arrangements and our ability to achieve and maintain profitable operations.

 

Therefore, management plans to raise equity capital to finance the operating and capital requirements of the Company. While the Company is devoting its best efforts to achieve the above plans, there is no assurance that any such activity will generate funds that will be available for operations. These conditions raise substantial doubt about the Company's ability to continue as a going concern.

 

Summary of any product research and development that we will perform for the term of our plan of operation.

 

At this time, the Company has no product research, nor development taking place, pending funding. As such, research is not required at this time.

 

Significant changes in the number of employees

 

We currently have a total of five employees, two of which serve as our officers, one employee who serves as the Company controller and two employees who work in the engineering and design facility. We are dependent upon our officers for our future business development. As our operations expand we anticipate the need to hire additional employees, consultants and professionals; however, the exact number is not quantifiable at this time.

 

Off-Balance Sheet Arrangements

 

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results or operations, liquidity, capital expenditures or capital resources that is material to investors.

 

 

 

 11 

 

 

Critical Accounting Policies and Estimates

 

Revenue Recognition: The Company recognizes revenue related to product sales when (i) persuasive evidence of the arrangement exists, (ii) shipment has occurred, (iii) the fee is fixed or determinable, and (iv) collectability is reasonably assured.

 

Recent Pronouncements

 

The Company's management has evaluated all the recently issued accounting pronouncements through the filing date of these financial statements and does not believe that any of these pronouncements will have a material impact on the Company's current financial position and results of operations.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

Not applicable

 

Item 4. Controls and Procedures

 

Disclosure Controls and Procedures

 

Disclosure controls and procedures are designed to ensure that information required to be disclosed in the reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported, within the time period specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including the CEO and CFO, as appropriate, to allow timely decisions regarding required disclosures. Our management necessarily applied its judgment in assessing the costs and benefits of such controls and procedures, which, by their nature, can provide only reasonable assurance regarding management’s control objectives.

 

Our management, with the participation of our CEO, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2023. Based upon this evaluation, our CEO concluded that our disclosure controls and procedures were not effective because of the identification material weaknesses in our internal control over financial reporting as described below.

 

Management’s Report on Internal Control Over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Rule 13a-15(f). Our internal control over financial reporting is a process designed to provide reasonable assurance to our management and board of directors regarding the reliability of financial reporting and the preparation of the financial statements for external purposes in accordance with U.S. GAAP.

 

Our internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. GAAP and our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our assets that could have a material effect on our financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. All internal control systems, no matter how well designed, have inherent limitations, including the possibility of human error and the circumvention of overriding controls. Accordingly, even effective internal control over financial reporting can provide only reasonable assurance with respect to financial statement preparation. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Our management assessed the effectiveness of our internal control over financial reporting as of September 30, 2023. In making this assessment, it used the criteria set forth by the Committee of Sponsoring Organizations of the Tread way Commission (“COSO”) in Internal Control-Integrated Framework (2013). Based on this evaluation, management concluded that our internal control over financial reporting was not effective as of September 30, 2023. Our CEO concluded we have material weaknesses due to lack of segregation of duties, a limited corporate governance structure, and a lack of a formal management review process over preparation of financial information. A material weakness is a deficiency, or a combination of control deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.

 

 

 12 

 

 

Our size has prevented us from being able to employ sufficient resources to enable us to have an adequate level of supervision and segregation of duties within our system of internal control. Therefore, while there are some compensating controls in place, it is difficult to ensure effective segregation of accounting and financial reporting duties. Management reported the following material weaknesses:

 

Certain reports that we prepare, and accounting and reporting conclusions reached in connection with the financial statement preparation process are not subjected to a formal review process that includes multiple levels of review and are not submitted timely to the Board of Directors for review or approval; and

 

Lack of segregation of duties in certain accounting and financial reporting processes including the initiation, processing, recording and approval of disbursements.

 

Our corporate governance responsibilities are performed by the Board of Directors, none of whom are independent under applicable standards; we do not have an audit committee or compensation committee. Our Board of Directors acts primarily by written consent without meetings which results in several of our corporate governance functions not being performed concurrent (or timely) with the underlying transactions, including evaluation of the application of accounting principles and disclosures.

 

The Company lacks adequate financial reporting capabilities – Due to the minimal operations and small size of the Company we have not employed individuals that have the necessary accounting knowledge and expertise to ensure accurate financial reporting under US GAAP.

 

The Company lacks appropriate information technology controls – As of September 30, 2023, the Company retains copies of all financial data and material agreements; however, there is no formal procedure or evidence of normal backup of the Company’s data or off-site storage of data in the event of theft, misplacement, or loss due to unmitigated factors.

 

While we strive to segregate duties as much as practicable, there is an insufficient volume of transactions at this point in time to justify additional full-time staff. We may not be able to fully remediate the material weaknesses until we expand operations at which time, we would expect to hire more staff. We will continue to monitor and assess the costs and benefits of additional staffing.

 

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

 

Changes in Internal Control Over Financial Reporting

 

During the nine months ended September 30, 2023, there were no changes in our internal controls over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) under the Exchange Act) that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 

 13 

 

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings

 

None

 

Item 1A. Risk Factors

 

Not applicable to smaller reporting companies

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

During the nine months ended September 30, 2023, the Company issued 6,005,400 shares of common stock to Mr. Powers, for $28,270 of debt and $8,539 for expense reimbursement. The shares were valued at $0.0816, the closing stock price on the date of grant, resulting in a loss on the issuance of $453,232.

 

The above shares were issued in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, for transactions not involving a public offering.

 

Item 3. Defaults Upon Senior Securities

 

None

 

Item 4. Mine Safety Disclosures

 

Not Applicable

 

Item 5. Other Information

 

None

 

Item 6. Exhibits

 

Exhibit No. Description
31 Certification of Chief Executive Officer and Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32 Certification of Chief Executive Officer and Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS* XBRL Instance Document
101.SCH* XBRL Taxonomy Extension Schema Document
101.CAL* XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF* XBRL Taxonomy Extension Definition Linkbase Document
101.LAB* XBRL Taxonomy Extension Label Linkbase Document
101.PRE* XBRL Taxonomy Extension Presentation Linkbase Document

 

*XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

 

Following are a list of exhibits which we previously filed in other reports which we filed with the SEC, including the Exhibit No., description of the exhibit and the identity of the Report where the exhibit was filed.

 

  3.1 Articles of Incorporation, as currently in effect, incorporated by reference to Form S-1 filed on 09/21/2021.

 

  3.2 Bylaws, as currently in effect, incorporated by reference to Form S-1 filed on 09/21/2021.

 

  3.3 Amended Designation filed with the State of Nevada on 12/30/15, incorporated by reference to Form 10-K for the year ended 12/31/22 filed on 4/4/23.

 

  3.4 Certificate of Amendment filed with the State of Nevada on 3/29/16, incorporated by reference to Form 10-K for the year ended 12/31/22 filed on 4/4/23.

 

 

 14 

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Findit, Inc.

 

/s/ Thomas Powers

By: Thomas Powers

Chief Executive Officer, Principal Executive Officer, Director

Date: November 20, 2023

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Company and in the capacities and on the dates indicated.

 

/s/Thomas Powers   CEO, Principal Executive, Director   November 20, 2023

 

/s/Raymond Firth

  CFO, President, Director   November 20, 2023

 

 

 

 

 15